Ambry Genetics and Invicro Announce Partnership

ALISO VIEJO, Calif.–(BUSINESS WIRE)–Ambry Genetics Corporation (Ambry), leaders in genetic testing, announced today they will partner with Invicro, a leading provider of imaging services and software for research and drug development, to provide customized genomics and imaging services for the pharmaceutical and biotechnology industry, with a specialized focus on oncology and neurodegenerative diseases.